Education
About Us
Working with TipRanks
Follow Us
AptarGroup (DE:AGT)
FRANKFURT:AGT
AGT Stock Chart & Stats
Day’s Range― - ―
52-Week Range€119.90 - €166.80
Previous CloseN/A
Volume0.00
Average Volume (3M)25.00
Market Cap
$8.87B
Enterprise Value€11.55B
Total Cash (Recent Filing)$125.84M
Total Debt (Recent Filing)$561.16M
Price to Earnings (P/E)25.7
Beta0.27
Next Earnings
Jul 31, 2025EPS Estimate
1.25Last Dividend Ex-Date
May 01, 2025Dividend Yield1.19%
Share Statistics
EPS (TTM)5.12
Shares Outstanding65,966,140
10 Day Avg. Volume20
30 Day Avg. Volume25
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.52
Enterprise Value/Ebitda15.22
Forecast
1Y Price Target
$154.92Price Target Upside16.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
AptarGroup News
PremiumCompany Announcements
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
PremiumCompany Announcements
AptarGroup’s Earnings Call: Growth Amid Challenges
---
Bulls Say, Bears Say
Bulls Say
EarningsAptar's first-quarter results beat expectations on profitability, and second-quarter EPS guidance exceeded forecasts.
Pharma GrowthImproving growth in Pharma is anticipated, with a clear path seen due to ramping-up capacity and strong demand trends in injectables.
Shareholder ReturnsImproving ROIC should support multiple expansion, with a five-year EPS CAGR expected to be upwards of 10%, combined with a roughly 1% dividend as an attractive total shareholder return.
Bears Say
Beauty Segment ChallengesFX and tax headwinds, remaining destocking, and the potential for continued China consumer weakness to weigh on Beauty segment results.
Consumer SpendingAptar’s Beauty segment, which makes up 34% of total sales, may see headwinds if consumer spending sentiments continue to stay low.
Sales PerformanceBeauty and Closures sales missed expectations.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.71% Insiders
32.62%
Mutual Funds
4.56% Other Institutional Investors
38.06% Public Companies and
Individual Investors
AGT FAQ
What was AptarGroup’s price range in the past 12 months?
AptarGroup lowest stock price was €119.90 and its highest was €166.80 in the past 12 months.
What is AptarGroup’s market cap?
AptarGroup’s market cap is $8.87B.
When is AptarGroup’s upcoming earnings report date?
AptarGroup’s upcoming earnings report date is Jul 31, 2025 which is in 88 days.
How were AptarGroup’s earnings last quarter?
AptarGroup released its earnings results on Feb 06, 2025. The company reported €1.339 earnings per share for the quarter, beating the consensus estimate of €1.107 by €0.232.
Is AptarGroup overvalued?
According to Wall Street analysts AptarGroup’s price is currently Undervalued.
Does AptarGroup pay dividends?
AptarGroup pays a Quarterly dividend of €1.589 which represents an annual dividend yield of 1.19%. See more information on AptarGroup dividends here
What is AptarGroup’s EPS estimate?
AptarGroup’s EPS estimate is 1.25.
How many shares outstanding does AptarGroup have?
AptarGroup has 65,966,140 shares outstanding.
What happened to AptarGroup’s price movement after its last earnings report?
AptarGroup reported an EPS of €1.339 in its last earnings report, beating expectations of €1.107. Following the earnings report the stock price went down -1.242%.
Which hedge fund is a major shareholder of AptarGroup?
Currently, no hedge funds are holding shares in DE:AGT
---
AptarGroup Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$154.92 (16.92% Upside)
$154.92 (16.92% Upside)
Blogger Sentiment
Bullish
DE:AGT Sentiment 66%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $215.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.88%
12-Months-Change
Fundamentals
Return on Equity
15.68%
Trailing 12-Months
Asset Growth
-0.44%
Trailing 12-Months
Company Description
AptarGroup
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
---
AGT Company Deck
---
AGT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the pharma and closure segments, significant returns to shareholders, and sustainability achievements. However, these were offset by challenges in the beauty segment, foreign currency and tax headwinds, and a decrease in consumer health care sales.Read More>---
AGT Stock 12 Month Forecast
Average Price Target
€154.92
▲(16.92% Upside)
Technical Analysis
Becton Dickinson
―
Hologic
―
Repligen
―
West Pharmaceutical Services
―
Stevanato Group
―
---